Your browser doesn't support javascript.
loading
Corrigendum to "Qiangguyin inhibited fat accumulation in OVX mice through the p38 MAPK signaling pathway to achieve anti-osteoporosis effects"[Biomed. Pharmacother. 158 (2023) 114122].
Wen, Jingyuan; Bao, Zhengsheng; Li, Lunxin; Liu, Yingquan; Wei, Bing; Ye, Xiaoang; Xu, Huihui; Cui, Longkang; Li, Xuefei; Shen, Gaobo; Fang, Yuan; Zeng, Hanbing; Shen, Zhe; Guo, Enping; Jin, Hongting; Wu, Lianguo.
Afiliación
  • Wen J; The Second Clinical College, Zhejiang Chinese Medical University, Hangzhou, China; The Second Affiliated Hospital of Zhejiang Chinese Medical University, Hangzhou, China.
  • Bao Z; The Second Clinical College, Zhejiang Chinese Medical University, Hangzhou, China; The Second Affiliated Hospital of Zhejiang Chinese Medical University, Hangzhou, China.
  • Li L; The Second Clinical College, Zhejiang Chinese Medical University, Hangzhou, China; The Second Affiliated Hospital of Zhejiang Chinese Medical University, Hangzhou, China.
  • Liu Y; The Second Clinical College, Zhejiang Chinese Medical University, Hangzhou, China; The Second Affiliated Hospital of Zhejiang Chinese Medical University, Hangzhou, China.
  • Wei B; The Second Clinical College, Zhejiang Chinese Medical University, Hangzhou, China; The Second Affiliated Hospital of Zhejiang Chinese Medical University, Hangzhou, China.
  • Ye X; The First Clinical College, Zhejiang Chinese Medical University, Hangzhou, China.
  • Xu H; The First Clinical College, Zhejiang Chinese Medical University, Hangzhou, China.
  • Cui L; The Second Clinical College, Zhejiang Chinese Medical University, Hangzhou, China; The Second Affiliated Hospital of Zhejiang Chinese Medical University, Hangzhou, China.
  • Li X; The Second Clinical College, Zhejiang Chinese Medical University, Hangzhou, China; The Second Affiliated Hospital of Zhejiang Chinese Medical University, Hangzhou, China.
  • Shen G; The Second Clinical College, Zhejiang Chinese Medical University, Hangzhou, China; The Second Affiliated Hospital of Zhejiang Chinese Medical University, Hangzhou, China.
  • Fang Y; The Second Clinical College, Zhejiang Chinese Medical University, Hangzhou, China; The Second Affiliated Hospital of Zhejiang Chinese Medical University, Hangzhou, China.
  • Zeng H; The Second Clinical College, Zhejiang Chinese Medical University, Hangzhou, China; The Second Affiliated Hospital of Zhejiang Chinese Medical University, Hangzhou, China.
  • Shen Z; The First Clinical College, Zhejiang Chinese Medical University, Hangzhou, China.
  • Guo E; The Second Affiliated Hospital of Zhejiang Chinese Medical University, Hangzhou, China.
  • Jin H; The First Clinical College, Zhejiang Chinese Medical University, Hangzhou, China. Electronic address: hongtingjin@163.com.
  • Wu L; The Second Clinical College, Zhejiang Chinese Medical University, Hangzhou, China. Electronic address: mdwu8535@126.com.
Biomed Pharmacother ; 176: 116914, 2024 Jul.
Article en En | MEDLINE | ID: mdl-38853031
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Idioma: En Revista: Biomed Pharmacother Año: 2024 Tipo del documento: Article País de afiliación: China
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Idioma: En Revista: Biomed Pharmacother Año: 2024 Tipo del documento: Article País de afiliación: China